Sonus Pharmaceuticals to Present TOCOSOL Paclitaxel Clinical Data in Metastatic Breast Cancer at San Antonio Breast Cancer Symposium
2nd Dec 2005, 23:05 GMT
Sonus Pharmaceuticals announced the scheduled presentation of a poster on TOCOSOL Paclitaxel at the upcoming San Antonio Breast Cancer Symposium, held in San Antonio, TX from December 8-11.
Sonus Pharmaceuticals to Present TOCOSOL Paclitaxel Clinical Data in Metastatic Breast Cancer at San Antonio Breast Cancer Symposium related news:
- Sonus Pharmaceuticals to Present TOCOSOL(R) Paclitaxel Clinical Data in Metastatic Breast Cancer at San Antonio Breast Cancer Symposium — RedOrbit News - Health
- Cytokinetics Announces Interim Phase II Breast Cancer Data for Ispinesib Presented at San Antonio Breast Cancer Symposium — Radiology News from StratCenter.com
- Bionovo Announces Presentation on Its Lead Anti-Cancer Compound at Upcoming San Antonio Breast Cancer Symposium — Radiology News from StratCenter.com
- The Susan G Komen Breast Cancer Foundation Names 2005 Recipients of Komen Brinker Award for Scientific Distinction — Mammography News from StratCenter.com
- Provectus Begins Phase 1 Breast Cancer Trial — Surgery News from StratCenter.com
- Provectus initiates phase I trial in breast cancer — Pharmaceutical Business Review Online
- Testing for breast cancer is getting more comfortable — The Cancer Blog
- American Pharmaceutical Partners to buy biggest shareholder — SacBee -- Business
- Predicting the sites of metastases — Genome Biology - Latest articles
- Vitae Pharmaceuticals Initiates Phase II Clinical Trials for 2 Novel Compounds for Psoriasis and Cancer Conditions — Operations-Related News from StratCenter.com